Production of polyunsaturated fatty acids by coexpression of acyl-CoA:lysophosphatidylcholine acyltransferases and phospholipid:diacylglycerol acyltransferases

US9416382B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9416382-B2
Application numberUS-201313916628-A
CountryUS
Kind codeB2
Filing dateJun 13, 2013
Priority dateJun 19, 2012
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Acyl-CoA:lysophosphatidylcholine acyltransferase [“LPCAT”] having the ability to convert acyl-CoA+1-acyl-sn-glycero-3-phosphocholine to CoA+1,2-diacyl-sn-glycero-3-phosphocholine (EC 2.3.1.23) is disclosed herein to be over-expressed along with the over-expression of phospholipid:diacylglycerol acyltransferase [“PDAT”] having the ability to transfer a fatty acyl group from the sn-2 position of a phospholipid (e.g., phosphatidylcholine) to the sn-3 position of 1,2-diacylglycerol [E.C.2.3.1.158], thus resulting in a lysophospholipid and TAG. Co-expression of these enzymes in a recombinant microbial host cell resulted in increased production of long chain polyunsaturated fatty acids [“PUFAs”].

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant microbial cell for the production of at least one long-chain polyunsaturated fatty acid, said recombinant microbial cell comprising: (a) at least one polypeptide having acyl CoA:lysophosphatidylcholine acyltransferase (LPCAT) activity, wherein the polypeptide having LPCAT activity has at least 95% amino acid sequence identity with the polypeptide of SEQ ID NO: 4 (YILPCAT), based on the Clustal W method of alignment, and wherein the polypeptide having LPCAT activity is a polypeptide comprising at least one mutant membrane-bound O-acyltransferase protein family motif comprising the amino acid sequence set forth in SEQ ID NO: 39, wherein the amino acid residue at position 2 of SEQ ID NO: 39 is C, the amino acid residue at position 3 of SEQ ID NO: 39 is selected from the group consisting of A, C and G, the amino acid residue at position 6 of SEQ ID NO: 39 is selected from the group consisting of H, G, N, and Y, the amino acid residue at position 7 of SEQ ID NO: 39 is selected from the group consisting of A, N, G, H and M, the amino acid residue at position 16 of SEQ ID NO: 39 is selected from the group consisting of Q, N, and H, and the amino acid residue at position 17 of SEQ ID NO: 39 is selected from the group consisting of A, V and N; (b) at least one polypeptide having phospholipid:diacylglycerol acyltransferase (PDAT) activity, wherein the polypeptide having PDAT activity has at least 95% amino acid sequence identity with the polypeptide of SEQ ID NO: 32 (YIPDAT), based on the Clustal W method of alignment; and (c) a polyunsaturated fatty acid biosynthetic pathway capable of producing at least one long chain polyunsaturated fatty acid; wherein said polypeptides of (a) and (b) are expressed, and wherein the recombinant microbial cell comprises an increased amount of a polyunsaturated fatty acid measured as a weight percent of total fatty acids, when compared to a control cell, wherein the control cell is the recombinant microbial cell wherein said polypeptides of (a) and (b) are not expressed. 2. The recombinant microbial cell of claim 1 , wherein the recombinant microbial cell further comprises at least one of the following, when compared to the control cell: (i) an increased C 18 to C 20 elongation conversion efficiency, or (ii) an increased amount of total fatty acids measured as a weight percent of dry cell weight. 3. The recombinant microbial cell of claim 2 , wherein the increased C 18 to C 20 elongation conversion efficiency is an effect of increased delta-9 elongase conversion efficiency or increased delta-6 elongase conversion efficiency. 4. The recombinant microbial cell of claim 1 , wherein the long-chain polyunsaturated fatty acid is selected from the group consisting of: eicosadienoic acid, dihomo-gamma-linolenic acid, arachidonic acid, docosatetraenoic acid, omega-6 docosapentaenoic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid, omega-3 docosapentaenoic acid and docosahexaenoic acid. 5. The recombinant microbial cell of claim 1 , wherein the microbial cell is selected from the group consisting of: algae, yeast, euglenoids, stramenopiles, oomycetes and fungi. 6. The recombinant microbial cell of claim 5 , wherein the cell is an oleaginous yeast. 7. The recombinant microbial cell of claim 6 , wherein the oleaginous yeast is of the genus Yarrowia. 8. The recombinant microbial cell of claim 1 , wherein the polypeptide having LPCAT activity comprises an amino acid sequence that (i) is at least 97% identical to SEQ ID NO: 4, and (ii) comprises substitutions at residues corresponding to residues 136 and 389 of SEQ ID NO: 4. 9. The recombinant microbial cell of claim 8 , wherein said residue corresponding to residue 136 is substituted with a serine or valine, and said residue corresponding to residue 389 is substituted with an alanine, cysteine, or serine. 10. A method for producing at least one polyunsaturated fatty acid comprising: (a) growing the recombinant microbial cell of claim 1 in the presence of a fermentable carbon source; and (b) optionally recovering the long-chain polyunsaturated fatty acid. 11. The method of claim 10 , wherein the recombinant microbial cell is an oleaginous yeast and the long-chain polyunsaturated fatty acid is selected from the group consisting of: eicosadienoic acid, dihomo-gamma-linolenic acid, arachidonic acid, docosatetraenoic acid, omega-6 docosapentaenoic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid, omega-3 docosapentaenoic acid and docosahexaenoic acid. 12. The method of claim 11 , wherein the oleaginous yeast is of the genus Yarrowia.

Assignees

Inventors

Classifications

  • for yeasts other than Saccharomyces · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • transferring groups other than amino-acyl groups (2.3.1) · CPC title

  • C12P7/6427Primary

    Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone · CPC title

  • C12P7/6432Primary

    Eicosapentaenoic acids [EPA] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9416382B2 cover?
Acyl-CoA:lysophosphatidylcholine acyltransferase [“LPCAT”] having the ability to convert acyl-CoA+1-acyl-sn-glycero-3-phosphocholine to CoA+1,2-diacyl-sn-glycero-3-phosphocholine (EC 2.3.1.23) is disclosed herein to be over-expressed along with the over-expression of phospholipid:diacylglycerol acyltransferase [“PDAT”] having the ability to transfer a fatty acyl group from the sn-2 position of …
Who is the assignee on this patent?
Du Pont
What technology area does this patent fall under?
Primary CPC classification C12P7/6427. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).